Background:
ChatGPT (Chat Generative Pre-trained Transformer) is a 175-billion-parameter natural language processing model, thereby already being involved in scientific contents and publications. Its influence ranges from providing quick access to information on medical topics, assisting to generate medical and scientific articles and papers, performing medical data analyses and even interpreting complex data sets.
Objective:
The future role of ChatGPT remains uncertain and a matter of debate already shortly after its release. The aim of this review was to analyze the role ChatGPT in medical literature during the first three months after its release.
Methods:
We here performed a concise review of literature published in PubMed from 12-1-2022 to 3-31-2023. In order to find all publications related to ChatGPT or considering ChatGPT, the search term was kept simple ("ChatGPT" in AllFields). All publications were included that were available as full text in German or English. All accessible publications were evaluated according to specifications by the author team, e.g. impact factor, publication modus, article type, publication speed, type of chat GPT integration or content. The conclusions of the articles were used for later SWOT (strengths, weaknesses, opportunities or threats) analysis. All data were analyzed on a descriptive basis.
Results:
Of 178 studies in total, 160 could be evaluated. The average impact factor was 4.423 (0 - 96.216), average publication speed was 16 days (0-83 days). Of all articles, there were 77 editorials, 43 essays, 21 studies, six reviews, six case reports, six news, and one meta-analysis. Of those, 54.4% were published as open access with 11% provided on preprint servers. Over 400 quotes with information on strengths, weaknesses, opportunities, and threats were detected. By far the most were related to weaknesses. ChatGPT excels in its ability to express ideas clearly and formulate general contexts comprehensibly. It performs so well that even experts in the field have difficulties in identifying abstracts generated by ChatGPT, whereas the time-limited scope and precisely the need for corrections by experts were mentioned as weaknesses and threats. Opportunities include assistance in formulating medical issues for non-native English speakers as well as the possibility of timely participation in the development of such artificial intelligence tools, since it is in its early stages and can therefore still be influenced.
Conclusions:
Artificial intelligence tools such as ChatGPT are already part of the medical publishing landscape. Despite apparent opportunities, policies and guidelines have to be implemented to ensure benefits in education, clinical practice and research rather than threats such as scientific misconduct, plagiarism or accuracy.